Immunome (IMNM.US) Stock Community - Hot Topic Discussions

Quote List Quote List

Event Tracking

Dec18

Immunome CEO Acquires Company Shares

22:04

Dec17

Immunome Launches Follow-On Public Offering to Raise $400 Million

22:26

Dec16

Craig-Hallum Analyst Reiterates Buy Rating on Immunome

14:57

Dec15

Immunome Announces Positive Phase III Trial Results for Varegacestat and Plans to Submit New Drug Application

12:02

Nov18

Lake Street analyst maintains a Buy rating on Immunome with a price target of $22

14:02

Nov7

Immunome released FY2025 9 Months Earnings on November 6 (EST), actual revenue USD 6.941 M, actual EPS USD -1.6763

04:00

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -57.46 M, EPS -0.6532

Aug6

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 4.015 M, Net Income -43.4 M, EPS -0.4987

May12

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 2.926 M, Net Income -41.64 M, EPS -0.5243

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change